Page 532 - O_Desenvolvimento_do_Autismo
P. 532

RINEHARDT, N.; BRADSHAW, J.; BRERETON, A. e TONGE, B.
                “Movement preparation in high-functioning autism and Asperger disorder: a
                serial choice reaction time task involving motor reprogramming”. Journal of

                Autism and Developmental Disorders 31, 2001, pp. 79-88.






                RISCH, N.; SPIKER, D.; LOTSPEICH, L.; NOURI, N.; HINDS, D.;
                HALLMAYER, J.; KALAYDJIEVA, L.; MCCAGUE, P.; DIMICELI, S.;
                PITTS, T.; NGUYEN, L.; YANG, J.; HARPER, C.; THORPE, D.;
                VERMEER, S.; YOUNG, C.; WIESE-SLATER, S.; ROGERS, T.; SALMON,
                B.; NICHOLAS, P.; PETERSEN, P. B.; PINGREE, C.; MCMAHON, W.;
                WONG, D.; CAVALLI-SFORZA, J. J.; KRAEMER, H. C. e MYERS, R. M.
                “A genomic screen of autism: evidence for a multilocus etiology”, American

                Journal of Human Genetics 65, 1999, pp. 493-507.






                ROBBINS, T. “Integrating the neurobiological and neuropsychological
                dimensions of autism”. In: J. Russell (ed.). Autism as an executive disorder.
                Oxford: Oxford University Press, 1997, pp. 21-53.






                ROBERTS, W.; WEAVER, L.; BRIAN, J.; BRYSON, S.; EMELIANOVA, S.;
                GRIFFITHS, A. M.; MACKINNON, B.; YIM, C.; WOLPIN, J. e KOREN, G.
                “Repeated doses of porcine secretin in the treatment of autism: a randomized,

                placebo-controlled trial”. Pediatrics 107, 2001, E71.






                ROBINSON, P.; SCHUTZ, C.; MACCIARDI, F.; WHITE, B. e HOLDEN, J.
                “Genetically determined low maternal serum dopamine beta-hydroxylase
                levels and the etiology of autism spectrum disorders”. American Journal
                Medical Genetics 100, 2001, pp. 30-36.
   527   528   529   530   531   532   533   534   535   536   537